vs
Amarin Corp plc（AMRN）与COMPX INTERNATIONAL INC（CIX）财务数据对比。点击上方公司名可切换其他公司
Amarin Corp plc的季度营收约是COMPX INTERNATIONAL INC的1.2倍（$45.1M vs $37.7M），COMPX INTERNATIONAL INC净利率更高（12.4% vs -23.3%，领先35.7%），Amarin Corp plc同比增速更快（7.0% vs -1.9%），过去两年COMPX INTERNATIONAL INC的营收复合增速更高（-0.4% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
COMPX国际是一家多元化安全与控制产品制造商，主营高性能锁具系统、电子门禁解决方案、人体工学工作站部件及船用五金，核心市场覆盖北美、欧洲，服务商业、住宅、工业、医疗、休闲船舶等领域客户。
AMRN vs CIX — 直观对比
营收规模更大
AMRN
是对方的1.2倍
$37.7M
营收增速更快
AMRN
高出8.9%
-1.9%
净利率更高
CIX
高出35.7%
-23.3%
两年增速更快
CIX
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $37.7M |
| 净利润 | $-10.5M | $4.7M |
| 毛利率 | — | 32.1% |
| 营业利润率 | 35.5% | 15.0% |
| 净利率 | -23.3% | 12.4% |
| 营收同比 | 7.0% | -1.9% |
| 净利润同比 | 33.0% | 3.6% |
| 每股收益（稀释后） | — | $0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNCIX
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | $37.7M | ||
| Q3 25 | $49.7M | $40.0M | ||
| Q2 25 | $72.7M | $40.4M | ||
| Q1 25 | $42.0M | $40.3M | ||
| Q4 24 | $62.3M | $38.4M | ||
| Q3 24 | $42.3M | $33.7M | ||
| Q2 24 | $67.5M | $35.9M |
净利润AMRNCIX
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | $4.7M | ||
| Q3 25 | $-7.7M | $4.2M | ||
| Q2 25 | $-14.1M | $5.5M | ||
| Q1 25 | $-15.7M | $5.1M | ||
| Q4 24 | $-48.6M | $4.5M | ||
| Q3 24 | $-25.1M | $3.5M | ||
| Q2 24 | $1.5M | $4.8M |
毛利率AMRNCIX
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | 32.1% | ||
| Q3 25 | 44.7% | 27.6% | ||
| Q2 25 | 69.2% | 31.9% | ||
| Q1 25 | 59.8% | 30.2% | ||
| Q4 24 | -15.4% | 28.8% | ||
| Q3 24 | 38.5% | 28.1% | ||
| Q2 24 | 63.4% | 31.1% |
营业利润率AMRNCIX
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | 15.0% | ||
| Q3 25 | -22.4% | 11.9% | ||
| Q2 25 | -22.0% | 15.7% | ||
| Q1 25 | -39.9% | 14.6% | ||
| Q4 24 | -84.3% | 12.7% | ||
| Q3 24 | -59.5% | 9.9% | ||
| Q2 24 | -0.8% | 14.2% |
净利率AMRNCIX
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | 12.4% | ||
| Q3 25 | -15.6% | 10.6% | ||
| Q2 25 | -19.4% | 13.5% | ||
| Q1 25 | -37.4% | 12.7% | ||
| Q4 24 | -78.0% | 11.7% | ||
| Q3 24 | -59.4% | 10.3% | ||
| Q2 24 | 2.3% | 13.5% |
每股收益（稀释后）AMRNCIX
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $0.38 | ||
| Q3 25 | $-0.02 | $0.34 | ||
| Q2 25 | $-0.03 | $0.44 | ||
| Q1 25 | $-0.04 | $0.42 | ||
| Q4 24 | $-0.12 | $0.37 | ||
| Q3 24 | $-0.06 | $0.28 | ||
| Q2 24 | $0.00 | $0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | $54.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $138.6M |
| 总资产 | $645.8M | $156.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMRNCIX
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | $54.1M | ||
| Q3 25 | $286.6M | $46.3M | ||
| Q2 25 | $298.7M | $56.2M | ||
| Q1 25 | $281.8M | $56.1M | ||
| Q4 24 | $294.2M | $60.8M | ||
| Q3 24 | $305.7M | $58.8M | ||
| Q2 24 | $306.7M | $82.1M |
股东权益AMRNCIX
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $138.6M | ||
| Q3 25 | $458.9M | $137.7M | ||
| Q2 25 | $464.9M | $149.5M | ||
| Q1 25 | $473.7M | $147.6M | ||
| Q4 24 | $486.2M | $146.1M | ||
| Q3 24 | $531.4M | $145.3M | ||
| Q2 24 | $551.9M | $170.2M |
总资产AMRNCIX
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | $156.2M | ||
| Q3 25 | $659.8M | $153.7M | ||
| Q2 25 | $670.1M | $164.8M | ||
| Q1 25 | $655.7M | $162.2M | ||
| Q4 24 | $685.3M | $163.0M | ||
| Q3 24 | $750.6M | $160.1M | ||
| Q2 24 | $799.9M | $185.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $12.0M |
| 自由现金流经营现金流 - 资本支出 | — | $11.4M |
| 自由现金流率自由现金流/营收 | — | 30.3% |
| 资本支出强度资本支出/营收 | — | 1.6% |
| 现金转化率经营现金流/净利润 | — | 2.57× |
| 过去12个月自由现金流最近4个季度 | — | $19.1M |
8季度趋势，按日历期对齐
经营现金流AMRNCIX
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | $12.0M | ||
| Q3 25 | $-12.7M | $6.3M | ||
| Q2 25 | $16.6M | $4.7M | ||
| Q1 25 | $-12.5M | $-137.0K | ||
| Q4 24 | $-13.3M | $7.3M | ||
| Q3 24 | $-2.4M | $4.1M | ||
| Q2 24 | $-2.7M | $9.8M |
自由现金流AMRNCIX
| Q1 26 | — | — | ||
| Q4 25 | — | $11.4M | ||
| Q3 25 | — | $5.3M | ||
| Q2 25 | — | $3.4M | ||
| Q1 25 | — | $-959.0K | ||
| Q4 24 | — | $7.1M | ||
| Q3 24 | — | $3.6M | ||
| Q2 24 | — | $9.4M |
自由现金流率AMRNCIX
| Q1 26 | — | — | ||
| Q4 25 | — | 30.3% | ||
| Q3 25 | — | 13.2% | ||
| Q2 25 | — | 8.4% | ||
| Q1 25 | — | -2.4% | ||
| Q4 24 | — | 18.5% | ||
| Q3 24 | — | 10.8% | ||
| Q2 24 | — | 26.2% |
资本支出强度AMRNCIX
| Q1 26 | — | — | ||
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 3.3% | ||
| Q1 25 | — | 2.0% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 1.4% | ||
| Q2 24 | — | 1.2% |
现金转化率AMRNCIX
| Q1 26 | — | — | ||
| Q4 25 | — | 2.57× | ||
| Q3 25 | — | 1.48× | ||
| Q2 25 | — | 0.87× | ||
| Q1 25 | — | -0.03× | ||
| Q4 24 | — | 1.62× | ||
| Q3 24 | — | 1.18× | ||
| Q2 24 | -1.81× | 2.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
CIX
| Security Products | $29.5M | 78% |
| Marine Components | $8.2M | 22% |
